Background illustration for clinical trials search

Paid Clinical Trials Vancouver

Discover 729 paid clinical trials in Vancouver, British Columbia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Vancouver, Surrey, Edmonds WA, Kirkland WA, Seattle WA,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

Noninvasive Spinal Cord Stimulation for Early SCI

for
Spinal Cord Injuries, Bowel Dysfunction, Sexual Dysfunction,
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 19 - 65

Code: NCT06587841

Recruiting

Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease

for
Lung Cancer, Interstitial Lung Disease
Location: Vancouver, London, Montreal, Saint John
Sponsor: David Palma

Sex: All

Age: 18+

Code: NCT05986318

Phase2, Recruiting

A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors

for
Triple Negative Locally Advanced Non-resectable Breast Cancer,
Location: Vancouver, Los Angeles CA, San Antonio TX, Nashville TN,
Sponsor: Marengo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06827613

Phase1, Phase2, Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: Vancouver, Oklahoma City OK, Grand Rapids MI,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06752681

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc

for
Cancer
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT04814095

Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Vancouver, Los Angeles CA, Toronto, Montreal,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06476808

Phase1, Recruiting

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Vancouver, Winnipeg, Ottawa, Montreal, Saint John
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT05371808

Recruiting

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Advanced Metastatic Castration-resistant Prostate Cancer,
Location: Vancouver, Hamilton, Toronto, Montreal, Sherbrooke
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06217822

Phase1, Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Vancouver, Seattle WA, Calgary, Edmonton, Palo Alto CA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05006716

Phase1, Phase2, Recruiting

Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease

for
Prostate Cancer
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: Male

Age: 18+

Code: NCT03836196

Recruiting

Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy

for
Adjuvant Radiotherapy for Breast Cancer
Location: Vancouver, Surrey, Prince George
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT04257396

Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Vancouver, Tacoma WA, Portland OR, Calgary, Edmonton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Vancouver, Seattle WA, Edmonton, Sacramento CA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase1, Phase2, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant
Location: Vancouver, Seattle WA, Portland OR, Edmonton,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase3, Recruiting

Exploring the Benefits of Pelvic Floor Muscle Training on Bladder, Bowel, and Sexual Function in People With Spinal Cord Injury

for
Spinal Cord Injury
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 19+

Code: NCT06705790

Recruiting

PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.

for
Ovarian Cancer, Primary Peritoneal Carcinoma,
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: Female

Age: 19 - 70+

Code: NCT03283943

Phase1, Recruiting

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)

for
Oligometastatic Prostate Cancer
Location: Vancouver, Victoria, Kelowna
Sponsor: British Columbia Cancer Agency

Sex: Male

Age: 18+

Code: NCT04610372

Recruiting

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

for
Oropharyngeal Cancer
Location: Vancouver, Portland OR, Duarte CA, Corona CA, Winnipeg,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT05451004

Phase3, Recruiting

CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer with Leptomeningeal Disease

for
EGFR Activating Mutation, Leptomeningeal Metastasis,
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT05257967

Recruiting